{"rows":[{"id":5733,"title":"Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement","authors":"Pérez Rosal Sergio R., Faber Sonya C.","journal":"Psychedelics","publication_date":"2026-12-01","publication_year":2026,"doi":"10.1016/j.psyche.2026.100029","pubmed_id":null,"openalex_id":"https://openalex.org/W7169607828","source_url":"https://doi.org/10.1016/j.psyche.2026.100029","substance_tags":"psilocybin","topic_tags":"Observational Study","study_type":"Observational Study","source_name":"Crossref","publication_status":"published","date_added":"2026-07-19 01:20:13","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100029","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100029","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.psyche.2026.100029","source_url":"https://doi.org/10.1016/j.psyche.2026.100029","doi":"10.1016/j.psyche.2026.100029","pmid":"","publication_date":"2026-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3113,"title":"Mindfulness-Based Psilocybin-Assisted Therapy (MB-PAT) for cancer-related demoralization in Canada: The case for a hybrid group-based delivery model","authors":"Albertyn Christopher P., Richard Jérémie, Shore Ron, Carlson Linda E.","journal":"Psychedelics","publication_date":"2026-12-01","publication_year":2026,"doi":"10.1016/j.psyche.2026.100032","pubmed_id":null,"openalex_id":"https://openalex.org/W7171862645","source_url":"https://doi.org/10.1016/j.psyche.2026.100032","substance_tags":"psilocybin","topic_tags":"Cancer Patients","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 11:03:46","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"DOI:10.1016/j.psyche.2026.100032","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.psyche.2026.100032","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.psyche.2026.100032","source_url":"https://doi.org/10.1016/j.psyche.2026.100032","doi":"10.1016/j.psyche.2026.100032","pmid":"","publication_date":"2026-12-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5679,"title":"Pupil-DLC: An open-source deep learning pipeline for scalable, marker-less tracking of pupil dynamics across conscious and unconscious states.","authors":"Seyfourian P, Marks LC, Claar LD, Nahas Y, Keating M, Koch C, Rembado I","journal":"Journal of neuroscience methods","publication_date":"2026-11-01","publication_year":2026,"doi":"10.1016/j.jneumeth.2026.110848","pubmed_id":"42401399","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/42401399/","substance_tags":"psilocybin","topic_tags":"Brain Imaging,Consciousness,Biomarkers,Aging,Animal Study","study_type":"Animal Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-09 01:20:07","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42401399","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42401399/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42401399","source_url":"https://pubmed.ncbi.nlm.nih.gov/42401399/","doi":"10.1016/j.jneumeth.2026.110848","pmid":"42401399","publication_date":"2026-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":64,"title":"Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression","authors":"Kelly Carlton M., Fradet Mathieu, Bostian Catherine M., Donnelly Anna, Ellis Sara, Ostacher Michael, Aaronson Scott, Suppes Trisha","journal":"Journal of Affective Disorders","publication_date":"2026-11-01","publication_year":2026,"doi":"10.1016/j.jad.2026.122063","pubmed_id":"42248535","openalex_id":"https://openalex.org/W7163510976","source_url":"https://doi.org/10.1016/j.jad.2026.122063","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Treatment-Resistant Depression,Veterans","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"PMID:42248535","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.jad.2026.122063","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42248535","source_url":"https://doi.org/10.1016/j.jad.2026.122063","doi":"10.1016/j.jad.2026.122063","pmid":"42248535","publication_date":"2026-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":302,"title":"Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats","authors":"Ladislavová Lucie, Kútná Viera, Mazochová Kristýna, Šíchová Klára, Danda Hynek, Lhotková Eva, Uttl Libor, Brejtr Vojtěch, Syrová Kateřina, Mazoch Vladimír, Horsley Rachel, Páleníček Tomáš","journal":"Pharmacology Biochemistry and Behavior","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1016/j.pbb.2026.174231","pubmed_id":"42379524","openalex_id":"https://openalex.org/W7166640155","source_url":"https://doi.org/10.1016/j.pbb.2026.174231","substance_tags":"psilocin","topic_tags":"Neurogenesis,Microdosing","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:48:03","last_checked":"2026-08-09 08:28:49","bibtex":null,"source_record_id":"PMID:42379524","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.pbb.2026.174231","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42379524","source_url":"https://doi.org/10.1016/j.pbb.2026.174231","doi":"10.1016/j.pbb.2026.174231","pmid":"42379524","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":120,"title":"Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults","authors":"Yang Kevin H., Satybaldiyeva Nora, Kepner Wayne, Friedman Joseph, Ping Siyuan, Leas Eric C.","journal":"American Journal of Preventive Medicine","publication_date":"2026-10-01","publication_year":2026,"doi":"10.1016/j.amepre.2026.108381","pubmed_id":"42092643","openalex_id":"https://openalex.org/W7160017394","source_url":"https://doi.org/10.1016/j.amepre.2026.108381","substance_tags":"psilocybin","topic_tags":"Microdosing","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:45","bibtex":null,"source_record_id":"PMID:42092643","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.amepre.2026.108381","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42092643","source_url":"https://doi.org/10.1016/j.amepre.2026.108381","doi":"10.1016/j.amepre.2026.108381","pmid":"42092643","publication_date":"2026-10-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5783,"title":"Single-crystal structure determination of psilocybin after dehydration","authors":"Emmett Sonya K., Cameron Lee, Hestermann Mark, Holland Darren, Kessler Simon, McFarlane Luke, Chooi Yit-Heng, Moggach Stephen A.","journal":"Acta Crystallographica Section C Structural Chemistry","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1107/s2053229626007692","pubmed_id":"42566287","openalex_id":"https://openalex.org/W7201840591","source_url":"https://doi.org/10.1107/s2053229626007692","substance_tags":"psilocybin","topic_tags":"General","study_type":"Clinical Trial","source_name":"Crossref","publication_status":"published","date_added":"2026-08-08 01:20:18","last_checked":"2026-08-14 01:20:15","bibtex":null,"source_record_id":"PMID:42566287","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1107/s2053229626007692","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42566287","source_url":"https://doi.org/10.1107/s2053229626007692","doi":"10.1107/s2053229626007692","pmid":"42566287","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4197,"title":"Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.","authors":"Husein A, Traylor M, Vest MF, Wood BJ, Brogan M, Thomas A, McNeil S, Bhuiyan MAN, Hendricks P, Kelly JR, Gribben A, Al-Qahtani MM, Keys K, Edinoff AN, Patterson JC, Murnane KS","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1177/28314425251381806","pubmed_id":"42539773","openalex_id":"https://openalex.org/W7117566828","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539773/","substance_tags":"psilocybin","topic_tags":"Addiction,Observational Study,Safety","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42539773","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42539773/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42539773","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539773/","doi":"10.1177/28314425251381806","pmid":"42539773","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":4190,"title":"A Nature-Themed Video Intervention Increases Nature Relatedness in Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.","authors":"Rich R, Laird K, Siddarth P, Youssef B, Schwartz GM, Ramos A, Sergi K, Linton M, Schwartzberg L, Kelly DF, Heinzerling KG","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1177/28314425251387655","pubmed_id":"42539824","openalex_id":"https://openalex.org/W7117646156","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539824/","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Wellbeing","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-04 06:34:37","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42539824","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42539824/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42539824","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539824/","doi":"10.1177/28314425251387655","pmid":"42539824","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1990,"title":"Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study.","authors":"Back AL, McGregor BA, Billingsley L, Blom D, Callan G, Myers S, Guy J, Kumar S, Layer M, Levin J, Perez J, Thompson P, Salmonson K, Whinney J, Thorn LL","journal":"Psychedelic medicine (New Rochelle, N.Y.)","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1177/28314425251404460","pubmed_id":"42539893","openalex_id":"https://openalex.org/W7116873484","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Emotional Processing,Clinical Trial,Cancer Patients,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:52:05","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42539893","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42539893","source_url":"https://pubmed.ncbi.nlm.nih.gov/42539893/","doi":"10.1177/28314425251404460","pmid":"42539893","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":301,"title":"Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress","authors":"Ibi Daisuke, Takaba Rika, Yoshida Keisuke, Kawase Ririna, Kitagawa Hiroko, Matsushita Momoko, Ito Kana, Uno Shoya, Nishimura Fumiya, Kitagaki Shinji, Hiramatsu Masayuki","journal":"Neuropsychopharmacology Reports","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1002/npr2.70152","pubmed_id":"42379141","openalex_id":"https://openalex.org/W7166665532","source_url":"https://doi.org/10.1002/npr2.70152","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Anxiety,Receptor Pharmacology,Resilience,Animal Study,Treatment-Resistant Depression","study_type":"Animal Study","source_name":"Crossref","publication_status":"published","date_added":"2026-07-01 06:48:03","last_checked":"2026-08-09 08:28:49","bibtex":null,"source_record_id":"PMID:42379141","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1002/npr2.70152","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42379141","source_url":"https://doi.org/10.1002/npr2.70152","doi":"10.1002/npr2.70152","pmid":"42379141","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":51,"title":"Balancing safety and access in Oregon’s psilocybin services","authors":"Cheung Katherine, Propes Caleigh, Yaden David B.","journal":"International Journal of Drug Policy","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1016/j.drugpo.2026.105384","pubmed_id":"42288041","openalex_id":"https://openalex.org/W7164654902","source_url":"https://doi.org/10.1016/j.drugpo.2026.105384","substance_tags":"psilocybin","topic_tags":"Safety","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:46","bibtex":null,"source_record_id":"PMID:42288041","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.drugpo.2026.105384","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42288041","source_url":"https://doi.org/10.1016/j.drugpo.2026.105384","doi":"10.1016/j.drugpo.2026.105384","pmid":"42288041","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":50,"title":"Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposases","authors":"Abrahms Zachary N., Majdi Mohammad, Madsen Siena M., Morton Chloe J., Sen Abhishek K., Fried Niya B., Sawyer Lily E., Cegielski Evelyn R., Spezzano Sean J., Jones J. Andrew","journal":"Metabolic Engineering","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1016/j.ymben.2026.102490","pubmed_id":"42288133","openalex_id":"https://openalex.org/W7164759173","source_url":"https://doi.org/10.1016/j.ymben.2026.102490","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Genomics","study_type":"Other","source_name":"Crossref","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:28:46","bibtex":null,"source_record_id":"PMID:42288133","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1016/j.ymben.2026.102490","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42288133","source_url":"https://doi.org/10.1016/j.ymben.2026.102490","doi":"10.1016/j.ymben.2026.102490","pmid":"42288133","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":46,"title":"Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review.","authors":"Cruz L, Beserra FR, Freind JMK, Rodrigues SE, Mograbi DC","journal":"Journal of clinical psychology","publication_date":"2026-09-01","publication_year":2026,"doi":"10.1002/jclp.70167","pubmed_id":"42296474","openalex_id":"https://openalex.org/W7164838909","source_url":"https://pubmed.ncbi.nlm.nih.gov/42296474/","substance_tags":"psilocybin","topic_tags":"Depression,PTSD,Clinical Trial,Systematic Review,Review Article","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:44","bibtex":null,"source_record_id":"PMID:42296474","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/42296474/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:42296474","source_url":"https://pubmed.ncbi.nlm.nih.gov/42296474/","doi":"10.1002/jclp.70167","pmid":"42296474","publication_date":"2026-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":3490,"title":"A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder","authors":"COMPASS Pathways","journal":"ClinicalTrials.gov","publication_date":"2026-08-18","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07570654","substance_tags":"psilocybin","topic_tags":"PTSD,Clinical Trial,Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-01 11:04:27","last_checked":"2026-08-19 01:24:01","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07570654","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07570654","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07570654","source_url":"https://clinicaltrials.gov/study/NCT07570654","doi":"","pmid":"","publication_date":"2026-08-18","importer_version":"2.1.3","text_redistributed":false}},{"id":5866,"title":"Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer Care","authors":"Christopher P. Albertyn, Ron Shore, Linda E. Carlson, Erika Dyck, David Clements","journal":null,"publication_date":"2026-08-17","publication_year":2026,"doi":"10.5281/zenodo.21983116","pubmed_id":null,"openalex_id":"https://openalex.org/W7203633773","source_url":"https://doi.org/10.5281/zenodo.21983116","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Mechanism of Action,Clinical Trial,Review Article,Healthcare Workers,Safety,Toxicity","study_type":"Clinical Trial","source_name":"OpenAlex","publication_status":"published","date_added":"2026-08-19 01:20:25","last_checked":"2026-08-19 01:20:25","bibtex":null,"source_record_id":"DOI:10.5281/zenodo.21983116","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.5281/zenodo.21983116","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.5281/zenodo.21983116","source_url":"https://doi.org/10.5281/zenodo.21983116","doi":"10.5281/zenodo.21983116","pmid":"","publication_date":"2026-08-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5865,"title":"Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks","authors":"Strika-Bruneau Lana, Elhssaini Chérine, Fauvel Baptiste, Kervadec Ewen, Bezo Aurore, Amirouche Ammar, Benyamina Amine, Romeo Bruno","journal":"Journal of Psychopharmacology","publication_date":"2026-08-17","publication_year":2026,"doi":"10.1177/02698811261473436","pubmed_id":"42609034","openalex_id":null,"source_url":"https://doi.org/10.1177/02698811261473436","substance_tags":"psilocybin","topic_tags":"Addiction,Mechanism of Action,Wellbeing,Clinical Trial,Systematic Review,Review Article,Safety,Drug Interactions","study_type":"Systematic Review","source_name":"Crossref","publication_status":"published","date_added":"2026-08-19 01:20:04","last_checked":"2026-08-19 01:20:19","bibtex":null,"source_record_id":"PMID:42609034","abstract_available":true,"abstract_source":"Crossref","abstract_source_url":"https://doi.org/10.1177/02698811261473436","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Crossref","source_record_id":"PMID:42609034","source_url":"https://doi.org/10.1177/02698811261473436","doi":"10.1177/02698811261473436","pmid":"42609034","publication_date":"2026-08-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5742,"title":"An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in Life","authors":"Charles Raison","journal":"ClinicalTrials.gov","publication_date":"2026-08-17","publication_year":2026,"doi":null,"pubmed_id":null,"openalex_id":null,"source_url":"https://clinicaltrials.gov/study/NCT07719088","substance_tags":"psilocybin,psilocin","topic_tags":"Neuroplasticity,Mechanism of Action,Biomarkers,Aging,Epigenetics,Cellular Senescence,Longevity,Oxidative Stress,Wellbeing,Clinical Trial,Observational Study,Animal Study,Older Adults,Safety","study_type":"Clinical Trial","source_name":"ClinicalTrials.gov","publication_status":"clinical trial","date_added":"2026-07-23 01:25:56","last_checked":"2026-08-19 01:24:02","bibtex":null,"source_record_id":"https://clinicaltrials.gov/study/NCT07719088","abstract_available":true,"abstract_source":"ClinicalTrials.gov","abstract_source_url":"https://clinicaltrials.gov/study/NCT07719088","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"ClinicalTrials.gov","source_record_id":"https://clinicaltrials.gov/study/NCT07719088","source_url":"https://clinicaltrials.gov/study/NCT07719088","doi":"","pmid":"","publication_date":"2026-08-17","importer_version":"2.1.3","text_redistributed":false}},{"id":5710,"title":"Prospective real-world evidence of mental health outcomes following supervised psilocybin services within the Oregon state-regulated model","authors":"Gow, A.; Shih, E.; Reid, R.; Qian, J. J.; Mellor, C.; McInnes, L. A.; Carhart-Harris, R.; Davis, J. N.","journal":"medRxiv","publication_date":"2026-08-17","publication_year":2026,"doi":"10.64898/2026.02.18.26346580","pubmed_id":null,"openalex_id":null,"source_url":"https://doi.org/10.64898/2026.02.18.26346580","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Wellbeing,Observational Study","study_type":"Observational Study","source_name":"medRxiv","publication_status":"preprint","date_added":"2026-07-11 19:28:11","last_checked":"2026-08-19 01:20:41","bibtex":null,"source_record_id":"DOI:10.64898/2026.02.18.26346580","abstract_available":true,"abstract_source":"medRxiv","abstract_source_url":"https://doi.org/10.64898/2026.02.18.26346580","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"medRxiv","source_record_id":"DOI:10.64898/2026.02.18.26346580","source_url":"https://doi.org/10.64898/2026.02.18.26346580","doi":"10.64898/2026.02.18.26346580","pmid":"","publication_date":"2026-08-17","importer_version":"2.1.3","text_redistributed":false}},{"id":3147,"title":"Defining 'psychedelic'.","authors":"Ostrand AE, Nour MM, Timmermann C, Rosati A, Luan LX, Gomez-Emilsson A, Bornemann J, Greenway KT, Roseman L, R CH.","journal":"Journal of psychopharmacology (Oxford, England)","publication_date":"2026-08-17","publication_year":2026,"doi":"10.1177/02698811261464986","pubmed_id":"42605589","openalex_id":null,"source_url":"https://doi.org/10.1177/02698811261464986","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"Europe PMC","publication_status":"published","date_added":"2026-07-01 11:03:47","last_checked":"2026-08-19 01:20:25","bibtex":null,"source_record_id":"PMID:42605589","abstract_available":true,"abstract_source":"Europe PMC","abstract_source_url":"https://doi.org/10.1177/02698811261464986","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"Europe PMC","source_record_id":"PMID:42605589","source_url":"https://doi.org/10.1177/02698811261464986","doi":"10.1177/02698811261464986","pmid":"42605589","publication_date":"2026-08-17","importer_version":"2.1.3","text_redistributed":false}}],"total":4961,"page":1,"per_page":20,"pages":249,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":null,"from":null,"to":null,"added_from":null,"added_to":null,"sort":"newest","page":1,"per_page":"20"}}